Mode
Text Size
Log in / Sign up

Narrative review links chronic stress and HPA dysregulation to cognitive dysfunction in ME/CFS.

Narrative review links chronic stress and HPA dysregulation to cognitive dysfunction in ME/CFS.
Photo by Brett Jordan / Unsplash
Key Takeaway
Consider HPA axis dysregulation as a potential target for cognitive dysfunction in ME/CFS.

This narrative review focuses on patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to evaluate the relationship between chronic stress, HPA axis dysregulation, and cognitive dysfunction. The scope includes secondary outcomes such as attention, memory, concentration, hippocampal structure, neuroinflammatory responses, and neurotransmitter homeostasis. The authors integrate current evidence to discuss potential mechanisms rather than reporting specific trial data or pooled effect sizes.

The text notes that chronic stress has been proposed as an important contributing factor and that dysregulation may be associated with cognitive dysfunction. However, the review does not report specific sample sizes, adverse events, or statistical significance levels. The authors distinguish between association and causation, using terms like 'proposed' and 'may be associated' to reflect the observational nature of the integrated evidence.

Limitations acknowledged include the lack of reported sample sizes and the theoretical nature of the conclusions. The review does not provide absolute numbers, event rates, or confidence intervals. Consequently, the practice relevance is framed as providing a theoretical basis for identifying potential intervention targets and informing strategies centered on HPA axis regulation, rather than offering definitive clinical guidelines.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Cognitive dysfunction is a common and disabling clinical feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), often described by patients as “brain fog.” These symptoms typically manifest as difficulties in attention, memory, and concentration. Chronic stress has been proposed as an important contributing factor in ME/CFS. The hypothalamic-pituitary-adrenal (HPA) axis plays a central role in the stress response, and prolonged adverse stress may contribute to HPA axis dysregulation, including altered cortisol rhythmicity and impaired negative feedback regulation. Such dysregulation may be associated with cognitive dysfunction in ME/CFS through mechanisms involving neuroinflammatory responses, oxidative stress, and disturbances in neurotransmitter homeostasis. Studies suggest that these alterations may affect hippocampal structure and function, thereby contributing to impaired learning and memory processes. As a key brain region involved in cognition and stress regulation, the hippocampus may be implicated in the neurobiological mechanisms underlying cognitive dysfunction in ME/CFS. This review integrates current evidence on the potential role of HPA axis dysregulation and related neurobiological alterations in chronic stress-associated cognitive dysfunction in ME/CFS, with the aim of providing a theoretical basis for identifying potential intervention targets and informing strategies centered on HPA axis regulation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.